Sudeep Pharma Ltd

Stage 2 · Advancing · week 4Setup 4.4 WatchEven +0.6

As of 16 Oct 2026, Sudeep Pharma is in Stage 2 — advancing, the uptrend phase, in week 4 (since 18 Sep 2026). It closed at ₹1,001, above its 200-day average. In Health Care, 40.0% of stocks are in Stage 2.

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in United States, Europe, United Kingdom, and Latin America. More about the company

₹1,000.7
-0.73% today
₹11,303 Cr · Mid cap
Market Neutral — FadingHealth Care 40.0% in Stage 2-7.4 pts / 20dPharmaceuticals 49.6%-2.5 pts

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

4.4 Watch

Momentum

Steady

Edge

Even +0.6

Setup-score rank among Stage 2 peers: #33 of 59 in Pharmaceuticals · #40 of 70 in Health Care

Is SUDEEPPHRM early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
—
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 4
1w13w26w
Week 4 — early Stage 2, building
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
24.5%
200 DMA: ₹803.8
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.41x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
MA20 rolling over · -6.5% vs MA50 +10.3%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-9.6%
3M
+16.0%
6M
+58.6%
YTD
+50.6%
1Y
—
Sector
Health Care
↓ Peaking
Stage 2%
40.0%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
Industry
Pharmaceuticals
↓ Peaking
Stage 2%
49.6%
20d Δ
-2.5pp
1M return
-2.3%
3M return
-0.6%
Industry Stage-2 % · last 20 days
Stage Cycle Timeline2025-11-28 → 2026-10-16
S? 42w
S2 4w
2025-11-282026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 42w → S2 4w current
Total tracked: 46 weeks across 2 stage runs.
Scan Membership
Prop Scan
Latest: 2026-10-07
Breakout Watch
Latest: 2026-09-18
14 appearances in last 60 days. First seen: 2026-09-18.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-16S2
Wk 4 · Vol 0.41x
2026-10-15S2
Wk 4 · Vol 0.36x
2026-10-14S2
Wk 4 · Vol 1.12x
2026-10-13S2
Wk 4 · Vol 1.31x
2026-10-12S2
Wk 4 · Vol 1.03x
2026-10-09S2
Wk 3 · Vol 1.80x
2026-10-08S2
Wk 3 · Vol 0.69x
2026-10-07S2
Wk 3 · Vol 0.66x
2026-10-06S2
Wk 3 · Vol 0.30x
2026-10-05S2
Wk 3 · Vol 0.52x
2026-10-01S2
Wk 2 · Vol 0.67x
2026-09-30S2
Wk 2 · Vol 0.58x
Sector Peers — Stage 2All →
BAFNAPH
wk 19 · 0.0% from hi
8.6
KILITCH
wk 3 · -11.6% from hi
8.4
LAURUSLABS
wk 26 · -0.4% from hi
7.8
KOPRAN
wk 20 · -6.8% from hi
7.4
ZIMLAB
wk 23 · -5.2% from hi
6.9
Moving averages & range
50 DMA
₹1,143.5
200 DMA
₹803.8
52W High
—
52W Low
—
5D Low
₹1,000.7
Resistance levels (recent highs)
20d High
₹1,205.8
60d High
₹1,344.2
120d High
₹1,344.2
250d High
—
Next resistance
+20.5%
to 20d High
Ask the Market AI about SUDEEPPHRMAsk →
P/E (TTM)
45.2
Forward 34.7
Earnings Growth (YoY)
+7.6%
Revenue +15.7%
ROE
+25.1%
Profit margin +25.8%
About this companyHealth Care· Pharmaceuticals

Sudeep Pharma Limited manufactures and sells excipients and specialty ingredients for the pharmaceutical, food, and nutrition industries in United States, Europe, United Kingdom, and Latin America. The company provides mineral salts, such as calcium, zinc, iron, potassium, magnesium, sodium, and copper to a range of health-focused applications; and calcium carbonate, which is used as an active pharmaceutical ingredient for various therapeutic applications. It also offers micronutrient premixes, encapsulated ingredients, liposomal and spray-dried formats, granulated minerals, and triturated blends to meet the needs across functional foods, dietary supplements, infant and clinical nutrition, fast-moving consumer goods, and convenience food formulations. In addition, the company is involved in manufacturing, developing, buying, selling, importing, exporting, trading, agency, testing, distributing, consigning, stocking, registering, packing, marketing, refining, and processing of pharmaceuticals, nutraceutical and nutrition products, food ingredients, mineral and vitamin blends, or premixes for infant, human and animal nutrition, and other chemical and healthcare products. Sudeep Pharma Limited was incorporated in 1989 and is based in Vadodara, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.